Zobrazeno 1 - 4
of 4
pro vyhledávání: '"aberrant PI3Kδ splice isoform"'
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
IntroductionPI3K/AKT signaling pathway is upregulated in a broad spectrum of cancers. Among the class I PI3Ks (PI3Kδ/β/δ isoforms), PI3Kδ has been implicated in hematologic cancers and solid tumors. Alternative splicing is a post-transcriptional
Externí odkaz:
https://doaj.org/article/1eae200900df4889b34fd432d1944e28
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kjer-Hansen P; EMBL Australia, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia. p.hansen@garvan.org.au.; St. Vincent's Healthcare Clinical Campus, School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Darlinghurst, New South Wales, Australia. p.hansen@garvan.org.au., Phan TG; St. Vincent's Healthcare Clinical Campus, School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Darlinghurst, New South Wales, Australia.; Precision Immunology Program, Garvan Institute of Medical Research, Sydney, New South Wales, Australia., Weatheritt RJ; EMBL Australia, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia. r.weatheritt@garvan.org.au.; School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, New South Wales, Australia. r.weatheritt@garvan.org.au.
Publikováno v:
Nature reviews. Drug discovery [Nat Rev Drug Discov] 2024 Oct; Vol. 23 (10), pp. 759-779. Date of Electronic Publication: 2024 Sep 04.
Autor:
Zhao Y; Key Lab for Arteriosclerology of Hunan Province, International Joint Laboratory for Arteriosclerotic Disease Research of Hunan Province, Institute of Cardiovascular Disease, University of South China, Hengyang, 421001, China., Yu B; Key Lab for Arteriosclerology of Hunan Province, International Joint Laboratory for Arteriosclerotic Disease Research of Hunan Province, Institute of Cardiovascular Disease, University of South China, Hengyang, 421001, China., Wang Y; Key Lab for Arteriosclerology of Hunan Province, International Joint Laboratory for Arteriosclerotic Disease Research of Hunan Province, Institute of Cardiovascular Disease, University of South China, Hengyang, 421001, China., Tan S; Key Lab for Arteriosclerology of Hunan Province, International Joint Laboratory for Arteriosclerotic Disease Research of Hunan Province, Institute of Cardiovascular Disease, University of South China, Hengyang, 421001, China., Xu Q; Key Lab for Arteriosclerology of Hunan Province, International Joint Laboratory for Arteriosclerotic Disease Research of Hunan Province, Institute of Cardiovascular Disease, University of South China, Hengyang, 421001, China., Wang Z; Key Lab for Arteriosclerology of Hunan Province, International Joint Laboratory for Arteriosclerotic Disease Research of Hunan Province, Institute of Cardiovascular Disease, University of South China, Hengyang, 421001, China., Zhou K; Key Lab for Arteriosclerology of Hunan Province, International Joint Laboratory for Arteriosclerotic Disease Research of Hunan Province, Institute of Cardiovascular Disease, University of South China, Hengyang, 421001, China., Liu H; Key Lab for Arteriosclerology of Hunan Province, International Joint Laboratory for Arteriosclerotic Disease Research of Hunan Province, Institute of Cardiovascular Disease, University of South China, Hengyang, 421001, China., Ren Z; Key Lab for Arteriosclerology of Hunan Province, International Joint Laboratory for Arteriosclerotic Disease Research of Hunan Province, Institute of Cardiovascular Disease, University of South China, Hengyang, 421001, China., Jiang Z; Key Lab for Arteriosclerology of Hunan Province, International Joint Laboratory for Arteriosclerotic Disease Research of Hunan Province, Institute of Cardiovascular Disease, University of South China, Hengyang, 421001, China. zsjiang2017@163.com.
Publikováno v:
Molecular and cellular biochemistry [Mol Cell Biochem] 2024 Apr 23. Date of Electronic Publication: 2024 Apr 23.